World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 88 13128 12358 147 142 594 29496

Yok-Lam Kwong publications per year

The chart shows the history of publications by Yok-Lam Kwong between 1988 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Yok-Lam Kwong published across 39 years, from 1988 to 2026, averaging 16.2 papers a year. Output peaked at 31 publications in 2010. 17 of the 631 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1988 to 2026. Vertical axis: number of publications, 0 to 31. Peak 31 publications in 2010. 1988: 1 publication 1989: 0 publications 1990: 1 publication 1991: 2 publications 1992: 5 publications 1993: 5 publications 1994: 4 publications 1995: 14 publications 1996: 8 publications 1997: 10 publications 1998: 6 publications 1999: 9 publications 2000: 9 publications 2001: 16 publications 2002: 17 publications 2003: 27 publications 2004: 26 publications 2005: 27 publications 2006: 22 publications 2007: 27 publications 2008: 22 publications 2009: 11 publications 2010: 31 publications 2011: 19 publications 2012: 27 publications 2013: 23 publications 2014: 25 publications 2015: 28 publications 2016: 23 publications 2017: 31 publications 2018: 18 publications 2019: 23 publications 2020: 18 publications 2021: 27 publications 2022: 22 publications 2023: 23 publications 2024: 7 publications 2025: 15 publications 2026: 2 publications
1988 2026

631 publications in total across all disciplines

View publications per year as a table
Yok-Lam Kwong: publications per year, 1988 to 2026
Year Publications
1988 1
1989 0
1990 1
1991 2
1992 5
1993 5
1994 4
1995 14
1996 8
1997 10
1998 6
1999 9
2000 9
2001 16
2002 17
2003 27
2004 26
2005 27
2006 22
2007 27
2008 22
2009 11
2010 31
2011 19
2012 27
2013 23
2014 25
2015 28
2016 23
2017 31
2018 18
2019 23
2020 18
2021 27
2022 22
2023 23
2024 7
2025 15
2026 2
Total 631
Download as CSV

Yok-Lam Kwong publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Yok-Lam Kwong sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 581–600 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 594 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509 594
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Yok-Lam Kwong D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Yok-Lam Kwong sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 88–89 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970 88
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Yok-Lam Kwong is affiliated with the University of Hong Kong in China and has a research focus primarily in the field of Medicine, with a specialization in Hematology. Their scholarly contributions cover a range of subfields including Hematology, Pathology and Forensic Medicine, Oncology, Genetics, and Molecular Biology.

The scientist's research topics include:

  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Viral-associated cancers and disorders
  • Retinoids in leukemia and cellular processes
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Chronic Myeloid Leukemia Treatments

Yok-Lam Kwong has contributed to numerous papers, including the following notable recent publications:

  • "Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma," 2021, New England Journal of Medicine
  • "How we treat NK/T-cell lymphomas," 2022, Journal of Hematology & Oncology
  • "Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy," 2022, Journal of Clinical Oncology
  • "Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma," 2020, Leukemia
  • "Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study," 2021, Journal of Hematology & Oncology

Throughout their career, Yok-Lam Kwong has frequently published in various academic venues, with the highest number of publications appearing in:

  • Annals of Hematology
  • Blood
  • Frontiers in Oncology
  • Hematology
  • HemaSphere

The scientist has collaborated extensively with several co-authors, among them:

  • Eric Tse
  • Harinder Gill
  • Rita Yim
  • Paul Lee
  • Joycelyn Sim

Best Publications

  • Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation

    Hung-Fat Tse;Yok-Lam Kwong;John K F Chan;Gladys Lo

  • Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.

    Anupama Reddy;Jenny Zhang;Nicholas S. Davis;Andrea B. Moffitt

  • Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

    Motoko Yamaguchi;Yok Lam Kwong;Won Seog Kim;Yoshinobu Maeda

  • The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9.

    Julian Borrow;Amanda M. Shearman;Vincent P. Stanton;Reinhard Becher

  • Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.

    Chee–Kin Hui;Winnie W.W. Cheung;Hai–Ying Zhang;Wing–Yan Au

  • Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index

    Chor-Sang Chim;Shing-Yan Ma;Wing-Yan Au;Carolyn Choy

  • PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase

    Yok-Lam Kwong;Thomas S. Y. Chan;Daryl Tan;Seok Jin Kim

  • SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group

    Yok-Lam Kwong;Won Seog Kim;Soon Thye Lim;Seok Jin Kim

  • Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.

    Cheuk Him Man;Tsz Kan Fung;Christa Ho;Heron H C Han

  • Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer

    A. O.-O. Chan;S.-K. Lam;B. C.-Y. Wong;W.-M. Wong

  • Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients.

    Wing-Yan Au;Annie Pang;Carolyn Choy;Chor-Sang Chim

  • How I treat NK/T-cell lymphomas

    Eric Tse;Yok-Lam Kwong

  • A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

    Seok Jin Kim;Dok Hyun Yoon;Arnaud Jaccard;Wee Joo Chng

  • SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway

    Chor-Sang Chim;Tsz-Kin Fung;Wai-Chung Cheung;Raymond Liang

  • CD56+ NK lymphomas: Clinicopathological features and prognosis

    Y. L. Kwong;A. C. L. Chan;R. Liang;A. K. S. Chiang

  • Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia

    Philipp Le Coutre;Oliver G. Ottmann;Francis Giles;Dong Wook Kim

  • Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study

    Wai-Kay Seto;Thomas S.Y. Chan;Yu-Yan Hwang;Danny Ka-Ho Wong

  • Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation.

    Anskar Y. H. Leung;Christine K. M. Suen;Albert K. W. Lie;Raymond H. S. Liang

  • The diagnosis and management of NK/T-cell lymphomas

    Eric Tse;Yok-Lam Kwong

  • Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years

    W.-Y. Au;S.-Y. Ma;C.-S. Chim;C. Choy

Frequent Co-Authors

Hung-Fat Tse
Hung-Fat Tse University of Hong Kong
Chu-Pak Lau
Chu-Pak Lau University of Hong Kong
John K.C. Chan
John K.C. Chan Tuen Mun Hospital
George K. K. Lau
George K. K. Lau Humanity & Health
Kwok-Yung Yuen
Kwok-Yung Yuen University of Hong Kong
Ritsuro Suzuki
Ritsuro Suzuki Shimane University
Irene Oi-Lin Ng
Irene Oi-Lin Ng University of Hong Kong
Ching-Lung Lai
Ching-Lung Lai University of Hong Kong
Man-Fung Yuen
Man-Fung Yuen University of Hong Kong
Vincent C. C. Cheng
Vincent C. C. Cheng University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine or healthcare, there are a range of related online programs designed to help you achieve your goals. Flexible online options make advanced education more accessible, allowing you to balance study with existing commitments.

For nurses wishing to take on advanced clinical roles, adn to np programs online offer a streamlined route from associate to nurse practitioner, opening doors in primary and specialized care. Those interested in combining food science and wellness can pursue an online nutrition degree, which can lead to roles in dietetics, public health, or the food industry.

Aspiring healthcare administrators may choose from top cahme accredited mha programs, focusing on management, policy, and organizational leadership within healthcare systems. Current registered nurses looking to advance their education without the need for onsite experience can explore online rn to bsn programs without clinicals for greater career mobility and higher earning potential.

No matter your area of interest, these accredited online pathways provide the skills and credentials needed to excel in today’s healthcare landscape.

Best Scientists Citing Yok-Lam Kwong

Trending Scientists

Recently Published Articles